Delivery Order SPE2DB22D1202-SPE2DB25FVHC1
Award Date 8/12/25
Potential Completion Date 9/3/25
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,039.40 to AmerisourceBergen Drug Corp for 50-unit vials of XEOMIN, a botulinum toxin product used for medical and therapeutic purposes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 28, 2025, and will be performed at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Xeomin, a botulinum toxin product commonly used for therapeutic and cosmetic applications in military and veteran healthcare settings. This firm fixed-price delivery order, valued at $2,514.33, was competitively awarded without set-aside provisions and is scheduled for completion by September 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performance...
- The Defense Logistics Agency awarded a $46,934.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of XEOMIN, a botulinum toxin product used for therapeutic and cosmetic medical applications. The contract, issued on August 19, 2025, with completion targeted for September 10, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This child contract leverages the...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $10,941.84 for XEOMIN 50 unit vials, a botulinum toxin product used for therapeutic and cosmetic purposes. The contract, designated as firm fixed price with no set-aside, was awarded on September 18, 2025, with an ultimate completion date of October 9, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $5,587.40 to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN, a botulinum toxin product used for medical and therapeutic purposes. This competitive award, issued on August 22, 2025, with an ultimate completion date of September 15, 2025, carries firm fixed pricing and represents a non-set-aside contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $1,676.22 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a botulinum toxin product commonly used for therapeutic and cosmetic medical applications. This firm fixed-price delivery order, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,793.70 delivery order for Xeomin 100 Unit Vials, a botulinum toxin product used for medical purposes. This competitive award, issued on August 25, 2025, carries an ultimate completion date of September 16, 2025, and utilizes firm fixed pricing with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under the company's...
- The Defense Logistics Agency awarded a $15,997.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of XEOMIN, a botulinum toxin product used for medical and cosmetic applications. The award, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen's Conshohocken, Pennsylvania facility serves as the place of performance for this transaction. This delivery...
- The Defense Logistics Agency awarded a $16,762.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of XEOMIN, a botulinum toxin product used for medical and therapeutic purposes. This non-set-aside competitive award, issued on April 24, 2025, with an ultimate completion date of May 15, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $8,381.10 to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a botulinum toxin-based therapeutic product used for medical applications. This non-set-aside, competitively awarded contract is issued under a firm fixed price structure with an ultimate completion date of September 19, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate...